Acquired pure red cell aplasia and recombinant erythropoietin
Recombinant erythropoietin (rEPO)-associated immunologically driven acquired pure red cell aplasia (PRCA) is an underreported, potentially worsening clinical syndrome in the setting of treatment of anemia of chronic kidney disease. Most cases reported in world literature are related to different for...
Main Authors: | Somanath Padhi, Sandip K Panda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;issue=4;spage=331;epage=335;aulast=Padhi |
Similar Items
-
PURE RED CELL APLASIA INDUCED BY ERYTHROPOIETIN
by: MIhajlovic Filip, et al.
Published: (2018-05-01) -
Acquired pure red cell aplasia in children
by: Sujata R Dafale, et al.
Published: (2012-01-01) -
Antibody-mediated pure red cell aplasia after treatment with darbepoetin-alpha postrenal transplantation
by: Badarinath Vellaboina, et al.
Published: (2019-01-01) -
Pure Red Cell Aplasia Associated with Good Syndrome
by: Masayuki Okui, et al.
Published: (2017-04-01) -
Pure red cell aplasia, a disease of a great diversity
by: Mona M Alfaraj, et al.
Published: (2020-01-01)